InflaRx (IFRX) Times Interest Earned (2016 - 2026)
InflaRx (IFRX) posted Times Interest Earned of $476.41 for Q1 2026, down 67.04% sequentially from $1445.4 in Q4 2025, and down 84.65% YoY from $3103.1 in Q1 2025.
InflaRx (IFRX) Times Interest Earned (2016 - 2026) Analysis & Trends
InflaRx has reported Times Interest Earned for 11 years, with the latest figure at $476.41 in Q1 2026.
- Quarterly Times Interest Earned fell 84.65% year-over-year to $476.41 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3223.3 (down 13699.07% YoY) and the FY2025 annual result came in at -$0.0, up 51.13% from the prior year.
- Times Interest Earned retreated to $476.41 in Q1 2026 per IFRX's latest filing, from $1445.4 in the prior quarter.
- Over five years, Times Interest Earned peaked at $3103.1 in Q1 2025 and troughed at -$3850.4 in Q2 2025.
- A 5-year average of $604.28 and a median of $660.0 in 2025 frame the typical range for Times Interest Earned.
- The sharpest annual moves came in 2023 and 2024: Times Interest Earned slumped 1526.41% in 2023, then jumped 140676646727929.6% in 2024.
- Over 5 years, Times Interest Earned stood at $1382.2 in 2022, then plunged by 129.8% to -$411.82 in 2023, then soared by 381.93% to $1161.0 in 2024, then climbed by 24.49% to $1445.4 in 2025, then slumped by 67.04% to $476.41 in 2026.
- According to Business Quant data, Times Interest Earned over the past three periods registered $476.41, $1445.4, and $660.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | InflaRx | 140.30 Mn | -43.96 Mn | 2.74 Bn | 481.53 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 476.41 |
| Dec 31, 2025 | 1,445.37 |
| Sep 30, 2025 | 660.00 |
| Jun 30, 2025 | -3,850.37 |
| Mar 31, 2025 | 3,103.11 |
| Dec 31, 2024 | 1,161.04 |
| Sep 30, 2024 | 3,052.47 |
| Jun 30, 2024 | -1,763.25 |
| Mar 31, 2024 | 2,696.18 |
| Dec 31, 2023 | -411.82 |
| Sep 30, 2023 | 2,277.08 |
| Jun 30, 2023 | -1,950.94 |
| Mar 31, 2023 | 0.00 |
| Dec 31, 2022 | 1,382.16 |
| Sep 30, 2022 | 1,255.55 |
| Jun 30, 2022 | 136.77 |
| Mar 31, 2022 | 602.99 |
| Dec 31, 2021 | 1,762.85 |
| Sep 30, 2021 | 1,336.48 |
| Jun 30, 2021 | 4,584.32 |